|
Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure |
1R01AA029594-01A1 |
|
NIAAA |
2022 |
|
Project 2: Prenatal Alcohol Exposure (PAE) and Fetal Alcohol Spectrum Disorder (FASD) |
1U54AA030451-01 |
|
NIAAA |
2022 |
|
Prenatal Alcohol Exposure and Fetal Alcohol Spectrum Disorder |
1U54AA030463-01 |
|
NIAAA |
2022 |
|
Prenatal Alcohol and Neuroimmunity |
5R01AA022460-08 |
|
NIAAA |
2022 |
|
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome |
5R01AI141662-04 |
|
NIAID |
2022 |
|
Macrophage mitochodrial reprogramming and innate immune memory |
5R01AI151210-03 |
|
NIAID |
2022 |
|
Probing the activity of DUX4 in FSHD |
5R01AR055685-13 |
|
NIAMS |
2022 |
|
Molecular Determinants of Pigmentation (MDoP) |
5R01AR077563-02 |
|
NIAMS |
2022 |
|
A theranostic system for ultrasound-facilitated blood-brain barrier opening |
5R01EB029338-03 |
|
NIBIB |
2022 |
|
Project 4: Whole-brain and body characterization of sleep disturbances and interventions in Fmr1, Shank3 and Cntnap2 knockout zebrafish |
1P50HD109861-01 |
|
NICHD |
2022 |